StockWatch
·
SONA BLW PRECISION FORGINGS LTD · QQ2 FY-2027 · THE CALL

Record quarter, margin pressure persists amid inflation and mix shift

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q2 FY27 resultsSONACOMSSona BLW Precision Forgings Ltd31 Oct 2026 · 6 min read
Verdict

Hold

confidence 7/10

Credibility

Grade B

Hit FY27 margin band (23% within 23–25%), beat revenue/PAT growth, executed on new products. Margin at lower end, recovery timeline vague.

Short-term outlook

Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

Sona delivered a record quarter with 35% YoY revenue growth and impressive new product/order wins, validating its diversification into EV and EPIC mobility. However, EBITDA margins remain compressed at 23% (vs 25.3% prior year) due to unfavorable product mix and inflation headwinds, delaying the recovery narrative. Management maintains 23–25% FY27 guidance but is candid that cost pass-through lags. Near-term catalyst: strong order book (₹251 Bn) and EPIC ramp; key risk: margin recovery timing and JV execution.

₹1546.4 Cr

Revenue · +35.2% YoY

₹223 Cr

Reported PAT · +30.8% YoY

Compressing

Margins · vs guidance: Corroborated

Did the claims hold up?

Management's claims vs. the numbers

Perfect quarter, highest ever revenue EBITDA PAT

MET

Revenue ₹1546 Cr (+35% YoY), EBITDA ₹356 Cr (+23%), PAT ₹223 Cr (+30.8%)

Margin recovery expected Q2 onwards as cost pass-throughs catch up

OVERSTATED

EBITDA margin 23% vs 25.3% Q2 FY26; recovery not yet visible, attributed to mix and inflation

EV business grew almost 50% QoQ, suspension motors fastest growing at 7% of revenue

MET

BEV revenue 51% of automotive; H1 BEV ₹1042 Cr +129% YoY; suspension motor growth strong but exact rate not disclosed

3rd highest order wins (₹36B), 2nd highest order book (₹251B)

MET

Confirmed ₹36B wins, ₹251B book

Commercialized 3 new products in Q2, highest ever

MET

Helical LSD, air springs, rear radar sensor delivered in Q2

Earnings quality

What changed since the last call

Deltas vs. the prior call

Margin recovery delayed

Downgrade

Q1 FY27 call: 'Q2 onwards recovery expected.' Q2 reality: 23% (vs 25.3%), no recovery; inflation and mix cited as culprits, not resolved.

EV penetration accelerated

Upgrade

BEV now 51% of automotive revenue (was 30% H1 FY26), +129% YoY; suspension motors and controllers winning at scale across geographies.

EPIC programs at 75 vs prior ambiguity

Upgrade

Management quantified 75 EPIC programs across 37 customers; 44 in production, 31 pending—concrete pipeline visibility.

No FY27 guidance cut despite headwinds

Neutral

FY27 EBITDA band 23–25% reaffirmed; not cut despite inflation, freight, and mix pressure. Maintained at lower end.

The Q&A

Analysts pressed hard on margin path (Basudeb Banerjee), robotics ROI timeline (Pramod Kumar), and Denso JV visibility (Arvind Sharma). Management held firm on 23–25% range, candid on margin lag but defensive on recovery timeline. Q&A tone: confident but hedged—Vivek acknowledged uncertainties (S-curve for new products, robotics inflection timing) without committing dates.

The exchanges that mattered

Suspension motor orders pipeline — Arvind Sharma, Nomura

Partial

Vivek acknowledged S-curve trajectory and consumer adoption risk; orders now span variants, future looks bright. Denso JV timing confidential due to legal/timeline.

Legacy (DA/DG) business growth horizon — Chandramauli Muthia

Dodged

Vivek: India's history of high world market share is rare; Sona has 9% in differential—no Indian company has high share in most products. Confident in continued growth.

Traction motor wallet share expansion mechanics — Gunjan Prithyani, Citi

Answered

Sat Mohan: Both wallet share and market growth driving increase; 3-wheeler programs launching, share still small but with large TAM.

EBITDA margin guidance evolution — Basudeb Banerjee

Answered

Vivek: 23–25% is fair, contingent on oil not spiking beyond ₹150/barrel. Inflation exceptional, product mix drag transparent; Rohit outlined path where margin stacks up in next 5 years.

Robotics humanoid deployment and ROI timeline — Pramod Kumar, Goldman Sachs

Dodged

Vivek: Does not know inflection point; acknowledged S-curve trajectory for new tech. Cost side moving fast, simulation lagging. Evaluating like any capex—business case + payback period driven.

Guidance

Forward guidance and management's confidence

No explicit FY27 revenue target; 10x over 10 years aspiration (CAGR ~26%)

Low

Sona 2.0 vision; dependent on EV penetration, EPIC ramp, robotics inflection—all uncertain timing.

FY27 EBITDA margin 23–25% reaffirmed (from Q1 call)

High

Maintained band, contingent on oil <₹150/barrel, material prices normalizing. Q2 at 23% (lower end); recovery narrative delayed.

Robotics capex: ₹62 Cr committed for Novelics AI/robotics; EPIC capex ongoing

Medium

Capex for capacity & new product tooling; actual robotics ROI and deployment pace uncertain; ₹250B order book growth supports capex case.

Risks the call surfaced

Ranked by how much they should concern a holder

Margin compression

High

EBITDA margin 23% (vs 25.3% prior year); driven by shift to traction motors and EV components (lower-margin) and inflation lag in cost pass-through. West Asia uncertainty adds freight volatility.

Supply chain stress

High

Traction motor demand surged almost 50% QoQ; while management says capacity exists, scaling production at this pace creates supply chain risk, especially for rare earth magnets and copper.

Customer concentration

Medium

Eastern markets now contribute 2/3 of revenue (up from 1/3 one year ago); geographic concentration and dependency on a few large OEMs. Diversification into new geographies ongoing but slower than concentration growth.

JV execution

Medium

Denso JV1 (high-voltage systems) carve-out targeted for Dec 2026 (or Jan 2027 if holidays slip); JV2 formation timeline 1H CY27. Delays would push revenue from DENSO JVs into FY28, impacting growth targets.

Robotics inflection timing

Medium

Robotics and physical AI aspiration ambitious; deployment timeline opaque. Pramod Kumar asked for inflection timeline; Vivek candidly said he doesn't know, acknowledging S-curve. ₹62 Cr capex committed but ROI and scale-up pace uncertain.

Management

Score 7/10. Transparent on challenges (margin pressure, inflation, mix dilution). Candid on uncertainties (robotics timeline, JV legal dependencies). Some evasion on Denso JV details and robotics inflection, citing confidentiality and complexity. Q&A handling mostly direct, with Vivek holding firm on guidance but hedging on near-term. Strong: Hit margin band (23% within 23–25%), beat revenue/PAT growth, delivered 3 new products, ₹36B order wins, ₹251B book secured. Track record of execution on diversification (EV now 51%) and product commercialization (highest rate). Margin lag vs. recovery narrative is the credibility dent.

What to watch next
  • 1 · H2 FY27

    EPIC programs ramp production (44/75 in production, 31 pending start)

  • 2 · Dec 2026

    JV1 carve-out (high-voltage systems SOP) closure targeted; JV2 formation in 1H CY27

  • 3 · FY27 end

    Robotics capability deployment; timeline for inflection opaque, aspiration only

Near-term catalyst: strong order book (₹251 Bn) and EPIC ramp; key risk: margin recovery timing and JV execution.

Informational and educational content only. Not investment advice.